Jump to content
RemedySpot.com

Update Confirms PROVENGE Improves Overall CaP Survival

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 10

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for

Prostate AdenoCarcinoma Treatment) study demonstrate that PROVENGE*

(sipuleucel-T) extends overall survival in men with metastatic,

castrate-resistant (hormone-refractory) prostate cancer

(CRPC). The data will be presented at the American Society of Clinical

Oncology 2010 Genitourinary Cancers Symposium (ASCO-GU) in San

Francisco on Friday, March 5 at 1:45 pm PT.....Click on the below link for the full story:<http://www.medicalnewstoday.com/articles/181163.php>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...